Analyst consensus rating
Atossa Therapeutics Analyst Rating: none
Direct answer
Atossa Therapeutics's consensus rating is none.
3 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $18.67.
Forecast evidence checked September 8, 2026.
Get free Atossa Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $2.57
- Average price target
- $18.67
- High price target
- $24.00
- Low price target
- $10.00
- Low target gap
- +289.1%
- Target upside
- +626.3%
- High target gap
- +833.9%
- Target range width
- 544.7%
- Consensus rating
- none
- Analysts
- 3
- Evidence date
- September 8, 2026
- Valid through
- September 15, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Atossa Therapeutics?
Atossa Therapeutics has a verified none consensus. The same dataset has an average price target of $18.67.
How far are Atossa Therapeutics's low and high targets from the recorded price?
The low target implies +289.1%, while the high target implies +833.9%.
How many analysts are included in Atossa Therapeutics's consensus?
The verified consensus includes 3 analysts.
How is Atossa Therapeutics's target upside or downside calculated?
The average target of $18.67 is divided by the recorded price of $2.57, then one is subtracted to produce +626.3%. This does not guarantee a future return.
When was Atossa Therapeutics's analyst forecast verified?
The data was verified on 2026-09-08. The dataset is valid through 2026-09-15.